• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.66% Nasdaq Up 0.88%

    Cancer Genetics, Inc. (CGIX)

    -NasdaqCM
    2.55 Down 0.11(4.14%) May 2, 4:00PM EDT
    Prev Close:2.66
    Open:2.70
    Bid:1.40 x 200
    Ask:N/A
    1y Target Est:6.08
    Beta:1.16396
    Earnings Date:May 10 - May 16 (Est.)
    Day's Range:2.51 - 2.67
    52wk Range:1.90 - 12.75
    Volume:59,328
    Avg Vol (3m):103,056
    Market Cap:34.81M
    P/E (ttm):N/A
    EPS (ttm):-2.04
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CGIX

    Comparison

    Symbol% ChgMkt Cap
    CGIXDown 4.14%34.81M
    MYGNUp 1.83%2.61B
    GHDXUp 3.61%898.77M
    RGDX 0.00%969.88K

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1.71
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.33
    Quarterly EPS Est (Mar-16) :-0.43
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cancer Genetics, Inc. develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, India, and China. Its tests enable physicians to personalize the clinical management of each individual patient by ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback